Completed (3)

Active, not recruiting (1)

phase 1 (2)

phase 1/phase 2 (1)

Children's Oncology Group (1)

Columbia University (1)

Morphotek (1)

National Cancer Institute (NCI) (1)

National Cancer Institute (NCI) (2)

Children's Oncology Group (1)

laboratory biomarker analysis (3)

pharmacological study (2)

anti-endosialin/tem1 monoclonal antibody morab-004 (1)

bendamustine (1)

brentuximab vedotin (1)

neulasta (1)

questionnaire administration (1)

sunitinib malate (1)

other (3)

drug (2)

biological (1)

Other (2)

Industry (1)

NIH (1)

Interventional (3)

Observational (1)

Anaplastic Large Cell Lymphoma

Showing NaN - NaN of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS